Clinical trials: MPAL

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia

HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide

• Active, not recruiting
• Age: 1 year and older
• Phase 2
• Surgery or procedure

This is a prospective, multi-center, Phase II study of hematopoietic cell transplantation (HCT) using human leukocyte antigen (HLA)-mismatched unrelated donors (MMUD) for peripheral blood stem cell transplant in adults and bone…

Conditions

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia, Acute Leukemia

Trial name

ACCESS (NCT04904588)

Testing

Busulfan, Fludarabine, Total-body irradiation

Where

39 sites in United States

Volunteers

300 people

Sponsor

Center for International Blood and Marrow Transplant Research